Regional Expansion Faes Farma has demonstrated strong international reach with products marketed or licensed in over 130 countries, presenting a sales opportunity to expand in regions where presence is growing, such as Latin America via the Uresco licensing deal with Dongkook Pharmaceutical.

Recent Growth First half 2026 results show revenue up 27 percent year over year and net profit of 57 million, signaling healthy financials and capacity to invest in new partnerships, product launches, or manufacturing capacity.

Portfolio Synergy Recent ophthalmic focus through the SIFI merger strengthens the specialty franchise; there is potential cross-sell of ophthalmology and prescription healthcare products to existing distributors in current markets.

Licensing Opportunities Exclusive licensing and supply agreement experience with Dongkook for Latin America demonstrates openness to regional partnerships; sales teams can target similar licensing deals or co-branded product launches in other underserved markets.

Sustainability and Quality Company aims to be a benchmark for reliability, quality, innovation and sustainability; align with global procurement teams seeking high-quality, compliant products and sustainable supply chains to tailor and win bids or tenders.